Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols. - Eren OC; Bagci P; Balci S; Ohike N; Saka B; Sokmensuer C; Leblebici CB; Xue Y; Reid MD; Krasinskas AM; Kooby D; Maithel SK; et al. (Annals of surgical oncology, 2024)